First Author: J.Chhablani INDIA
Co Author(s): P.K. Rani A. Mathai S. Jalali I. Kozak 0 0 0 0 0 0 0 0 0
Back to previous
To assess the efficacy of navigated laser treatment in treatment for central serous chorioretinopathy (CSCR).
Tertiary Eye Care Center
Prospective study included 16 eyes of 15 subjects with non-resolving CSCR. All subjects underwent fluorescein angiography (FA) and navigated laser photocoagulation. Pre-treatment best corrected visual acuity (BCVA), central macular thickness (CMT), number of leaks on FA, treatment parameters including total number of shots for each leaking spot, average power used, post-treatment BCVA and CMT were noted. Patient’s pain experience was evaluated using the Visual Analog Pain Scale (VAS).
Total 16 eyes of 15 subjects (12 males and three females) were enrolled with mean age of 42.2 ± 9.9 years. Mean duration of symptoms was 11.45 ±16.6 months. Mean pre-treatment BCVA and post-treatment BCVA at 2 months was 0.28 (approximately 20/40) and 0.17 (approximately 20/30) logMAR respectively (p=0.171). Average number of leaks per eye was 2.8 and one laser spot photocoagulation per leak was performed. Average spot size was 94±9.48 microns. Mean power used for each laser spot was 106.1±32.0 mW. Mean CMT was 337.1±231.5 and 165±61.8 microns at baseline and at two months follow up (p=0.007). Complete resolution of subretinal fluid at 2 months of follow up was noted in 15 out of 16 eyes. Average VAS score was 0.63±1.41.
Navigated laser treatment without contact lens achieved resolution of subretinal fluid with single laser spot for a single leak with minimum power. Laser planning and treatment on the computer screen, makes navigated laser a preferred option for extrafoveal leaks in CSCR.